EX-99.1 2 dex991.htm SERIES A PREFERRED STOCK PURCHASE AGREEMENT DBS NOMINEES (PRIVATE) LIMITED, (as Lead Investor), SEAVI ADVENT EQUITY V (A) LTD, (as Co- Investor and together with the Lead Investor, the Investors), Mr. CHI KWONG WAN, Mr. XUEXIANG...Series a Preferred Stock Purchase Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Series A Preferred Stock Purchase Agreement (this Agreement) is made as of October 28, 2009, by and among Sinocom Pharmaceutical, Inc., a Nevada corporation (the Company), Mr. Chi Kwong Wan, Mr. Xuexiang Ai and Eastern Wealthy International Invest Limited, a British Virgin Islands limited company (each a Key Shareholder and collectively the Key Shareholders), DBS Nominees (Private) Limited, a limited private company incorporated in Singapore (the Lead Investor) and each of the persons and entities listed on the Schedule of Investors on Schedule 2.1 (together with the Lead Investor, the Investors). The Company and the Key Shareholders are hereinafter collectively referred to as the Company Parties.
DBS NOMINEES (PRIVATE) LIMITED, (as Lead Investor), SEAVI ADVENT EQUITY V (A) LTD, (as Co-Investor and together with the Lead Investor, the Investors), Mr. CHI KWONG WAN, Mr. XUEXIANG AI and EASTERN WEALTHY INTERNATIONAL INVEST LIMITED (together as...Series a Preferred Stock Purchase Agreement • December 14th, 2009 • DBS Nominees (Private) LTD • Blank checks • New York
Contract Type FiledDecember 14th, 2009 Company Industry JurisdictionThis Series A Preferred Stock Purchase Agreement (this Agreement) is made as of October 28, 2009, by and among Sinocom Pharmaceutical, Inc., a Nevada corporation (the Company), Mr. Chi Kwong Wan, Mr. Xuexiang Ai and Eastern Wealthy International Invest Limited, a British Virgin Islands limited company (each a Key Shareholder and collectively the Key Shareholders), DBS Nominees (Private) Limited, a limited private company incorporated in Singapore (the Lead Investor) and each of the persons and entities listed on the Schedule of Investors on Schedule 2.1 (together with the Lead Investor, the Investors). The Company and the Key Shareholders are hereinafter collectively referred to as the Company Parties.
SERIES A PREFERRED STOCK PURCHASE AGREEMENTSeries a Preferred Stock Purchase Agreement • October 30th, 2009 • Sinocom Pharmaceutical, Inc. • Blank checks • New York
Contract Type FiledOctober 30th, 2009 Company Industry JurisdictionThis Series A Preferred Stock Purchase Agreement (this Agreement) is made as of October 28, 2009, by and among Sinocom Pharmaceutical, Inc., a Nevada corporation (the Company), Mr. Chi Kwong Wan, Mr. Xuexiang Ai and Eastern Wealthy International Invest Limited, a British Virgin Islands limited company (each a Key Shareholder and collectively the Key Shareholders), DBS Nominees (Private) Limited, a limited private company incorporated in Singapore (the Lead Investor) and each of the persons and entities listed on the Schedule of Investors on Schedule 2.1 (together with the Lead Investor, the Investors). The Company and the Key Shareholders are hereinafter collectively referred to as the Company Parties.